Active	Status	Sponsor type	Region	Phase	Filter
12 Active 6 Inactive 18 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

12 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wu, Mai-Szu
NCT04543812: PBF-1681 (Ferric Citrate) for the Treatment of IDA in Patients With NDD-CKD	Completed	3	141	RoW	Ferric citrate, Placebo	Panion & BF Biotech Inc.	Anemia of Chronic Kidney Disease	10/22	12/22
ALIGN, NCT04573478: Atrasentan in Patients With IgA Nephropathy	Active, not recruiting	3	404	Europe, Canada, Japan, US, RoW	Atrasentan, CHK-01, Atrasentan Hydrochloride, ABT-627, Placebo	Chinook Therapeutics, Inc.	IgA Nephropathy, Immunoglobulin A Nephropathy	12/26	12/26
REGEN-006, NCT05099770: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease	Recruiting	3	685	Europe, Canada, US, RoW	Renal Autologous Cell Therapy (REACT), Sham Comparator	Prokidney, Iqvia Pty Ltd, PPD	Type 2 Diabetes Mellitus, Chronic Kidney Diseases	02/27	02/27
SURMOUNT-MMO, NCT05556512: A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity	Active, not recruiting	3	15374	Europe, Canada, Japan, US, RoW	Tirzepatide, LY3298176, Placebo	Eli Lilly and Company	Obesity, Overweight	10/27	10/27
NCT02933827: Adipose-derived Stem Cells (ADSCs) for Moderate to Severe Chronic Kidney Disease	Completed	1/2	39	RoW	ELIXCYTE	UnicoCell Biomed CO. LTD, Protech Pharmaservices Corporation (PPC)	Moderate to Severe Chronic Kidney Disease	04/19	06/23
NCT05174221: A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy	Active, not recruiting	1	16	Europe, Japan, US, RoW	Mezagitamab, TAK-079	Takeda	Kidney Disease, Glomerulonephritis	03/26	03/26
Chang, Tung-Cheng
NCT06184438: Randomized Control Trial of Micronized Purified Flavonoid Fraction for Post Operative Treatment in Anal Fistula Surgery	Recruiting	4	150	RoW	Micronized purified flavonoid fraction(Daflon 1000mg), diosmin, hesperidin, Placebo, Control group	Taipei Medical University Shuang Ho Hospital	Anal Fistula	12/25	03/26
NCT05831956: The Efficacy and Safety of Using Collagen Patch on Anastomotic Site in Colorectal Surgery	Completed	N/A	241	RoW	Laparoscopic colectomy	Taipei Medical University Shuang Ho Hospital	Anastomosis, Functional	02/23	03/23
NCT05602987: Comparison Study of the Effect of Enema in Anal Surgery	Completed	N/A	282	RoW	enema, no enema	Taipei Medical University Shuang Ho Hospital	Hemorrhoids, Fistula	09/23	10/23
NCT05605080: Hemostatic and Analgesic Effect of Gel Foam and Gauze With Bosmin After Anal Surgery	Completed	N/A	292	RoW	Gelfoam, Bosmin gauze	Taipei Medical University Shuang Ho Hospital	Hemorrhoids, Anal Fistula	10/23	11/23
NCT05580471: A Randomized Control Study of Anti-Adhesion Agent After Colorectal Surgery	Recruiting	N/A	40	RoW	Use 4DryField	Taipei Medical University Shuang Ho Hospital	Adhesion	09/24	09/24
Chao, Jane
NCT05926375: Effect of HINEX Jelly on Nutritional Status in People With Possible Sarcopenia or Sarcopenia	Active, not recruiting	N/A	60	RoW	HINEX Jelly ( jelly high protein supplement)	Taipei Medical University, Taiwan Otsuka Pharm. Co., Ltd	Sarcopenia	03/23	06/23